The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation[1] – the alteration of nerve activity through the delivery of electrical stimulation or chemical agents to targeted sites of the body. Neuromodulation is a burgeoning field—analysts predict a 27 percent annual growth rate over the next four years.[2] Founded in 1989 and based in San Francisco, CA, the INS educates and promotes the field through meetings, its quarterly, peer-reviewed journal Neuromodulation: Technology at the Neural Interface and chapter websites.
Neuromodulation: Technology at the Neural Interface is the official publication of the INS. The journal aims to advance the basic and clinical science of the field of neuromodulation.
Contents |
In 1989, after the first International Congress on Epidural Spinal Cord Stimulation was held in the Netherlands, a group of physicians founded the INS in Paris, France. Their incentive was to bridge the gap between neurologists, neurosurgeons, vascular surgeons and cardiologists to build a multidisciplinary and international society dedicated to the advancement of neuromodulation.
The International Neuromodulation Society now represents a professional association of more than 1200 members worldwide and has a presence in 33 countries around the globe. The INS was named the 2007 Most Valuable Nonprofit Society by Neurotech Reports and was awarded the Golden Electrode Award at the 2007 Neurotech Leaders Forum.
The ninth biennial Congress of the INS will be held in Seoul, Korea in 2009.